Product Name: REGENO Cartalax + TB-500 + BPC-157 Strength: 30mg Total Peptide Content Blend Composition: Cartalax 10mg TB-500 10mg BPC-157 10mg Chemical Name: Multi-Peptide Research Blend (Cartalax + TB-500 + BPC-157) Appearance: White to Off-White Lyophilized Powder Classification: Multi-Peptide Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Composite Peptide Research Tissue Organization Studies Extracellular Matrix Research Cartilage Signaling Studies Cellular Migration Research Store lyophilized material refrigerated at 28C for routine storage
Bacteriostatic water includes 0.9% Benzyl Alcohol as an antimicrobial preservative
On WADA's 2026 Prohibited List, BPC-157 falls under S0 (Non-Approved Substances), while TB-500 falls under S2, the peptide hormones and growth factors section
These pathways are crucial for blood vessel formation, repair, and overall vascular health
Hubungi tim kami untuk mendapatkan informasi lebih lanjut mengenai layanan, konsultasi, maupun peluang kerja sama.
That is what supervised peptide therapy looks like compared to sourcing and self-administering without clinical oversight